Skip to content

Novel GABAAR-α6 Subtype Selective Ligands for Pain and CNS Disorders

Safe and metabolically stable novel GABA A receptor ligands specific to the alpha 6 subtype (GABAAR-α6) for CNS disorders and pain.

Published: 8th September 2020
Novel GABAAR-α6 Subtype Selective Ligands for Pain and CNS Disorders
Header image is purely illustrative. Source: Siarhei, stock.adobe.com
IP Status
  • Patent application submitted
Seeking
  • Development partner
  • Licensing